Trial intelligence / Profile preview

Bone marrow collection in healthy volunteers for Neuro-Cells manufacturing validation

NL-OMON52489Recruiting

Sponsor
Neuroplast
Start
Jun 2018
Modality
Stem Cell Therapies → Cell Therapies
Countries
1
01

Overview

Open-label, single-arm trial of Neuro-Cells in spinal cord injury (SCI) and amyotrophic lateral sclerosis (ALS), sponsored by Neuroplast. Started Jun 2018; status: recruiting.

02

Drugs

Neuro-Cells
03

Conditions

spinal cord injury (SCI)amyotrophic lateral sclerosis (ALS)

Beyond the preview

Go deeper on NL-OMON52489.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON52489.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call